Pharmacology and Emerging Therapies for Group 3 Pulmonary Hypertension Due to Chronic Lung Disease

Pulmonary hypertension (PH) frequently complicates chronic lung disease and is associated with high morbidity and poor outcomes. Individuals with interstitial lung disease and chronic obstructive pulmonary disease develop PH due to structural changes associated with the destruction of lung parenchym...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzales, Janae, Fraidenburg, Dustin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058846/
https://www.ncbi.nlm.nih.gov/pubmed/36986517
http://dx.doi.org/10.3390/ph16030418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058846/
https://www.ncbi.nlm.nih.gov/pubmed/36986517
http://dx.doi.org/10.3390/ph16030418

Ejemplares similares